Researchers Overcome Radiation Resistance in Leukemia With an Engineered Precision Medicine (IMAGE)

Elsevier

Researchers Overcome Radiation Resistance in Leukemia With an Engineered Precision Medicine

Caption

CD19L-sTRAIL selectively binds to the CD19 receptor on leukemia cells via its CD19L moiety upon which its sTRAIL component kills the cells by engaging the TRAIL death receptors.

Credit

Dr Fatih Uckun, CHLA-USC

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.